Frankfurt - Delayed Quote EUR
Sinopharm Group Co. Ltd. (X2S.F)
2.0600
-0.0350
(-1.67%)
At close: May 21 at 8:01:39 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
11,546,015
11,546,015
17,173,030
20,963,787
9,308,085
Investing Cash Flow
-3,750,925
-3,750,925
-944,535
-3,589,622
-1,266,962
Financing Cash Flow
-17,285,034
-17,285,034
-7,643,970
-5,693,481
-14,693,007
End Cash Position
54,313,359
54,313,359
63,808,538
55,221,624
43,529,428
Capital Expenditure
-1,968,077
-1,968,077
-2,335,850
-2,417,529
-2,255,642
Issuance of Capital Stock
3,621,347
--
--
--
0
Issuance of Debt
106,925,809
106,925,809
106,438,067
106,450,900
99,921,730
Repayment of Debt
-114,656,605
-114,656,605
-103,936,790
-101,705,335
-104,707,104
Free Cash Flow
9,577,938
9,577,938
14,837,180
18,546,258
7,052,443
12/31/2021 - 5/16/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade